Warner Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MSR
PR
SO
WT
AAS
WAM
RFM
NHFG
RAM
Warner Financial's XBI Position: Q2 2026 in Review
Warner Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.93% in Q2 2026, buying an estimated $3.79K and bringing the position to 3,023 shares worth $478K. The position accounts for 0.14% of the portfolio, ranked #94.
Warner Financial first reported a position in XBI in Q4 2021 and has held it in 16 quarters since. The position peaked at $831K in Q2 2023. 394 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Warner Financial held 3,023 shares of State Street SPDR S&P Biotech ETF worth $478K as of Q2 2026.
- Warner Financial bought 28 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.79K.
- State Street SPDR S&P Biotech ETF made up 0.14% of Warner Financial's portfolio in Q2 2026, its #94 holding.
- Warner Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 16 quarters since.
- Warner Financial's State Street SPDR S&P Biotech ETF position peaked at $831K in Q2 2023.
- 394 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.